Health In Tech, Inc. (HIT) Q1 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call highlights strong financial performance with 56% revenue growth, improved operating leverage, and a solid cash position. The company's strategic focus on AI-backed underwriting and channel distribution supports future growth. Despite competitive pressures and economic risks, management's confidence in maintaining gross margins and operating leverage is positive. The lack of a share repurchase program is a neutral factor. Overall, the positive financial metrics, strategic initiatives, and optimistic guidance suggest a positive stock price movement in the next two weeks.
Key Financial Performance
Revenue $8 million, reflecting 56% year-over-year growth, driven by rising market demand and the continued strength of our platform.
Income Before Income Tax $0.7 million, a 257% increase compared to the same period last year, highlighting the scalability of our model and efficiency of our cost structure.
Enrolled Employees 24,307, up from 20,802 in Q1 2024, representing a 17% increase, driven by strong demand for new product offerings.
Gross Profit $5.3 million, with a gross margin of 66.8%, expected to be maintained due to strategic pivot to a channel distribution model.
Total Operating Expenses $4.9 million, an increase of $1.1 million from the prior year, with $0.6 million related to public company costs and $0.5 million from share-based compensation.
Operating Expenses as a Percentage of Revenue 61%, down from 74% a year ago, reflecting strong operating leverage.
Sales and Marketing Expenses $1.1 million, in line with the previous year, but as a percentage of revenue, it declined to 13.6% from 20.4% in Q1 2024.
Research and Development Expenses $0.5 million, down from $0.8 million in the same period last year, due to capitalization of development costs.
Adjusted EBITDA $1.2 million, more than doubling from $0.5 million in Q1 last year.
Cash and Cash Equivalents $7.6 million at quarter end, indicating a solid balance sheet.
Accounts Receivable $2.1 million, with an average collection period of 28 days, reflecting disciplined management.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
AI-backed underwriting capabilities: Continued advancement of AI-backed underwriting capabilities within the eDIYBS platform, designed for mid-to large-sized businesses. Full-scale rollout expected in Q3 2025.
Collaboration with DialCare: Strategic collaboration with DialCare to integrate telehealth services into self-funded health plan offerings, enhancing access to healthcare for members.
Expansion of broker network: Number of active brokers on the platform increased to 459, more than doubling from 192 in the same period last year.
Revenue growth: Achieved $8 million in revenue, reflecting 56% year-over-year growth.
Gross profit and margin: Gross profit reached $5.3 million with a gross margin of 66.8%.
Operating expenses: Operating expenses decreased as a percentage of revenue to 61%, down from 74% a year ago.
Board of Directors addition: Welcomed Sanjay Shrestha to the Board, bringing experience in scaling platform businesses and capital markets.
Focus on operational efficiency: Continued focus on operational efficiency to support sustainable growth and reinvest in innovation.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Economic Factors: Employers are under growing pressure to manage their costs due to current microeconomic challenges, which may impact demand for Health In Tech's services.
Competitive Pressures: The company is focused on differentiating its offerings in a competitive market, particularly with the launch of its AI-backed underwriting capabilities to capture a new segment of the self-funded market.
Regulatory Issues: The company acknowledges potential risks associated with regulatory changes that could affect its business operations and market strategies.
Supply Chain Challenges: While not explicitly mentioned, the growth in demand for their services may lead to challenges in scaling operations and maintaining service quality as they expand their broker network.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue Growth: Achieved $8 million in revenue, reflecting 56% year-over-year growth.
AI-backed Underwriting: Continued advancement of AI-backed underwriting capabilities within the eDIYBS platform, with a full-scale rollout expected in Q3 2025.
Collaboration with DialCare: Strategic collaboration with DialCare to integrate telehealth services into Health In Tech's offerings.
Broker Network Expansion: Increased active brokers on the platform to 459, more than doubling from 192 in the same period last year.
Board Appointment: Welcomed Sanjay Shrestha to the Board of Directors to leverage his experience in scaling platform businesses.
Future Revenue Expectations: Expect strong sales momentum to continue into Q2 2025.
Operating Leverage: Confident in achieving operating leverage and solid bottom line results.
Gross Margin: Expect to maintain gross margins at 66.8%.
Cash Position: Solid balance sheet with $7.6 million in cash and cash equivalents.
Strategic Investments: Focus on evaluating new opportunities with financial rigor to support sustainable growth.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Share Repurchase Program: None
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Should we think about the growth in the number of enrolled employees in terms of any seasonality?
A:January 1 is typically our best month due to many groups renewing their health insurance. The percentage increase month over month this year will be significantly better than last year.
Q:Can you give us more color on how you're segmenting your target market, especially for employers with 1,000 or more employees?
A:The expansion beyond 150 enrolled employees to 1,000 is for convenience. The technology we are bringing allows for better communication and efficiency between brokers and underwriters.
Q:Could you explain the difference between your underwriting and fee revenues?
A:We earn revenue as a percentage of premiums from underwriting and program fees from healthcare plans for small business owners.
Q:What is the health of the self-funded market?
A:Most larger groups are self-funded today, which provides them with flexibility. Over 90% of companies with 150 lives or more are self-funded.
Q:Are there management teams concerned about taking the risk of self-funding?
A:Yes, but we mitigate risk through different layers of coverage limits within the policy.
Q:Will your AI-powered underwriting platform have a different pricing basis?
A:No, it will improve the process but not change pricing.
Q:What does it mean to look for channel partners?
A:Channel partners bring distribution and customers, allowing us to reach brokers more effectively.
Q:How does your collaboration with DialCare compare to your standard offering?
A:DialCare has a proprietary health program that allows for flat fees for specific services, making underwriting easier.
Q:Review of Unclear Management Responses
A:Management did not provide a clear answer regarding the specific market space for self-funded groups above 150 employees, stating they did not know the exact percentage.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Albany Capital
Allen Klee
Capital Markets
Capital insight
DialCare care
DialCare provider
Director Marin
Director Qian
Directors track
ET Transcript
Form SEC
Group Conference
Inc Chief
Investment Research
Lazard Capital
Marin Zacks
Markets Albany
Members demand
Mr afternoon
Ms Qian
Ms today
Officer Qian
Qian Chief
Qian result
Research Allen
SEC document
Shrestha Directors
Tech Conference
Tech self
Transcript Alpha
Zacks Investment
ability
collaboration DialCare
eDIYBS broker
efficiency focus
healthcare solution
HIT Transcript
Health In Tech, Inc. (HIT) Q3 2025 Earnings Call Transcript
Positive11-11
The earnings call reflects strong financial health with improved operating expenses and positive cash flow. Strategic partnerships and product innovations are expected to drive growth. Despite some uncertainties in the large employer market, the company's initiatives like the 3-year rate hold and blockchain development are promising. The Q&A session revealed positive analyst sentiment, although some details were withheld. Overall, the positive financial performance and strategic growth plans suggest a positive stock price movement in the near term.
Health In Tech, Inc. (HIT) Q2 2025 Earnings Call Transcript
Positive7-23
The earnings call summary indicates strong financial performance with positive cash flow, effective cost management, and strategic partnerships driving growth. The Q&A reveals management's proactive approach in leveraging partnerships and technology for market expansion, despite some vague responses about new products. The company's solid financial health and growth strategy, coupled with a significant market opportunity, suggest a positive stock price movement. However, the lack of specific guidance on new products and potential expansion limits the sentiment from being 'strong positive.'
Health In Tech, Inc. (HIT) Q1 2025 Earnings Call Transcript
Positive4-16
The earnings call highlights strong financial performance with 56% revenue growth, improved operating leverage, and a solid cash position. The company's strategic focus on AI-backed underwriting and channel distribution supports future growth. Despite competitive pressures and economic risks, management's confidence in maintaining gross margins and operating leverage is positive. The lack of a share repurchase program is a neutral factor. Overall, the positive financial metrics, strategic initiatives, and optimistic guidance suggest a positive stock price movement in the next two weeks.
Health In Tech, Inc. (HIT) Q4 2024 Earnings Call Transcript
Unknown3-21
The earnings call presented mixed signals: strong early 2025 revenue momentum and disciplined capital management were positives, but declining margins, increased expenses, and lack of shareholder returns were concerns. The Q&A highlighted management's cautious approach to guidance, which could dampen investor enthusiasm. Overall, the financial results and cautious outlook suggest a neutral stock price reaction in the near term.
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
